TY - JOUR AU - Jack, C. R. PY - 2010 DA - 2010// TI - Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade JO - Lancet Neurol VL - 9 UR - https://doi.org/10.1016/S1474-4422(09)70299-6 DO - 10.1016/S1474-4422(09)70299-6 ID - Jack2010 ER - TY - JOUR AU - Hardy, J. AU - Selkoe, D. J. PY - 2002 DA - 2002// TI - The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics JO - Science VL - 297 UR - https://doi.org/10.1126/science.1072994 DO - 10.1126/science.1072994 ID - Hardy2002 ER - TY - JOUR AU - Dubois, B. PY - 2010 DA - 2010// TI - Revising the definition of Alzheimer's disease: a new lexicon JO - Lancet Neurol VL - 9 UR - https://doi.org/10.1016/S1474-4422(10)70223-4 DO - 10.1016/S1474-4422(10)70223-4 ID - Dubois2010 ER - TY - JOUR AU - Golde, T. E. AU - Petrucelli, L. AU - Lewis, J. PY - 2010 DA - 2010// TI - Targeting Abeta and tau in Alzheimer's disease, an early interim report JO - Exp Neurol VL - 223 UR - https://doi.org/10.1016/j.expneurol.2009.07.035 DO - 10.1016/j.expneurol.2009.07.035 ID - Golde2010 ER - TY - JOUR AU - Imbimbo, B. P. AU - Giardina, G. A. PY - 2011 DA - 2011// TI - gamma-secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes JO - Curr Top Med Chem VL - 11 UR - https://doi.org/10.2174/156802611795860942 DO - 10.2174/156802611795860942 ID - Imbimbo2011 ER - TY - JOUR AU - Golde, T. E. AU - Schneider, L. S. AU - Koo, E. H. PY - 2011 DA - 2011// TI - Anti-abeta therapeutics in Alzheimer's disease: the need for a paradigm shift JO - Neuron VL - 69 UR - https://doi.org/10.1016/j.neuron.2011.01.002 DO - 10.1016/j.neuron.2011.01.002 ID - Golde2011 ER - TY - JOUR AU - Das, P. PY - 2001 DA - 2001// TI - Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition JO - Neurobiol Aging VL - 22 UR - https://doi.org/10.1016/S0197-4580(01)00245-7 DO - 10.1016/S0197-4580(01)00245-7 ID - Das2001 ER - TY - JOUR AU - Abramowski, D. PY - 2008 DA - 2008// TI - Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition JO - J Pharmacol Exp Ther VL - 327 UR - https://doi.org/10.1124/jpet.108.140327 DO - 10.1124/jpet.108.140327 ID - Abramowski2008 ER - TY - JOUR AU - Levites, Y. PY - 2006 DA - 2006// TI - Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model JO - J Clin Invest VL - 116 UR - https://doi.org/10.1172/JCI25410 DO - 10.1172/JCI25410 ID - Levites2006 ER - TY - JOUR AU - Jarrett, J. T. AU - Lansbury, P. T. PY - 1993 DA - 1993// TI - Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? JO - Cell VL - 73 UR - https://doi.org/10.1016/0092-8674(93)90635-4 DO - 10.1016/0092-8674(93)90635-4 ID - Jarrett1993 ER - TY - JOUR AU - Kawarabayashi, T. PY - 2001 DA - 2001// TI - Age-Dependent Changes in Brain, CSF, and Plasma Amyloid Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease JO - J Neurosci VL - 21 ID - Kawarabayashi2001 ER - TY - JOUR AU - Dovey, H. AU - Varghese, J. AU - Anderson, J. P. PY - 2000 DA - 2000// TI - Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in the brain JO - J Neurochem VL - 76 ID - Dovey2000 ER - TY - JOUR AU - Wong, G. T. PY - 2004 DA - 2004// TI - Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M311652200 DO - 10.1074/jbc.M311652200 ID - Wong2004 ER - TY - JOUR AU - Karlnoski, R. A. PY - 2009 DA - 2009// TI - Suppression of amyloid deposition leads to long-term reductions in Alzheimer's pathologies in Tg2576 mice JO - J Neurosci VL - 29 UR - https://doi.org/10.1523/JNEUROSCI.4560-08.2009 DO - 10.1523/JNEUROSCI.4560-08.2009 ID - Karlnoski2009 ER - TY - JOUR AU - Fauq, A. H. PY - 2007 DA - 2007// TI - A multigram chemical synthesis of the gamma-secretase inhibitor LY411575 and its diastereoisomers JO - Bioorg Med Chem Lett VL - 17 UR - https://doi.org/10.1016/j.bmcl.2007.07.062 DO - 10.1016/j.bmcl.2007.07.062 ID - Fauq2007 ER - TY - JOUR AU - Chakrabarty, P. PY - 2010 DA - 2010// TI - Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition JO - FASEB J VL - 24 UR - https://doi.org/10.1096/fj.09-141754 DO - 10.1096/fj.09-141754 ID - Chakrabarty2010 ER - TY - JOUR AU - Chakrabarty, P. PY - 2010 DA - 2010// TI - IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice JO - J Immunol VL - 184 UR - https://doi.org/10.4049/jimmunol.0903382 DO - 10.4049/jimmunol.0903382 ID - Chakrabarty2010 ER -